A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of PBF-999 in the Treatment of Patients with Prader-Willi Syndrome.
This research study is testing a new medicine called PBF-999 for people who have Prader-Willi Syndrome. The main aims are to find out if the medicine is safe and if it causes any side effects. We also want to see how well it works to help people with their condition. Another part of the study is to understand how the medicine is absorbed and used by the body. This is an early stage of testing (called a Phase 2 study), where a small group of people try the medicine to help us learn more before it can be offered to more people. Participants will take PBF-999 or a dummy pill (placebo) to see the difference.
Auf einen Blick
Worum geht es in dieser Studie?
This study is about a new medicine, PBF-999, for people who have Prader-Willi Syndrome. Prader-Willi Syndrome is a complex genetic condition that affects many parts of the body. People with Prader-Willi Syndrome can experience a range of symptoms, and researchers are always looking for new ways to help manage these.
In this study, we are trying to find out if PBF-999 is safe to use and what effects it might have. This is an important step because before any new medicine can be approved for general use, it needs to be thoroughly tested. We will be looking closely at any side effects people experience, which we call 'adverse events', to make sure the medicine is well-tolerated. We will also be using questionnaires to understand how the medicine might be affecting people's quality of life and general well-being.
We'll also collect some information about how the body handles PBF-999, such as how much of the medicine gets into the blood and how long it stays there. This helps us understand the best way to give the medicine. By carefully studying these things, we hope to learn if PBF-999 could be a helpful new treatment option for people with Prader-Willi Syndrome in the future.
Wichtige Erkenntnisse
- This study is testing a new medicine (PBF-999) for Prader-Willi Syndrome.
- It aims to check if the medicine is safe and how well it works.
- Participants will receive either PBF-999 or a dummy pill (placebo).
- It's open to adults aged 18 and older, both men and women.
- You'll have regular hospital visits for health checks and questionnaires.
- Sie können die Teilnahme jederzeit beenden, wenn Sie möchten.
Wer könnte berechtigt sein?
To be part of this study, you need to be at least 18 years old. There's no upper age limit, so people of all adult ages can take part. The study is open to both men and women.
More specific details about who can and cannot join will be discussed by the study team. For example, they will check your medical history to make sure taking part is safe for you. It's important that you meet all the study requirements to ensure the results are accurate and reliable.
If you're interested, the research team will review your health information and explain everything carefully to see if this study is right for you.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Sind Sie 18 Jahre alt oder älter?
- Do you have a diagnosis of Prader-Willi Syndrome?
- Are you able to attend regular appointments at the study clinic?
- Are you comfortable potentially receiving a placebo (dummy pill) instead of the active medicine?
- Are you willing to provide blood and urine samples?
Was beinhaltet die Teilnahme?
If you decide to take part in this study, you'll be given either the new medicine PBF-999 or a 'dummy' pill (called a placebo). A placebo looks just like the real medicine but contains no active ingredients. Neither you nor the study team will know if you are taking the actual medicine or the placebo. This helps us get clearer results.
Taking part will involve regular visits to the study clinic. During these visits, the study team will carry out health checks, ask you questions about how you're feeling, and take blood or urine samples. They might use questionnaires to understand how the treatment is affecting you and measure certain body markers. The exact number of visits and their individual length will be explained by the study team, along with the total duration you'll be involved in the study.
Potenzielle Risiken und Vorteile
Standorte (1)
- —UnbestätigtSpanien
Häufige Fragen
What is Prader-Willi Syndrome?
Prader-Willi Syndrome is a complex genetic condition that affects many parts of the body, including growth, development, and appetite.
What is a 'Phase 2' study?
A Phase 2 study is an early stage of testing a new medicine. It helps us learn more about if the medicine is safe, how well it works, and what doses might be best, after initial safety checks.
Was ist ein 'Placebo'?
A placebo is a 'dummy' pill that looks just like the study medicine but doesn't contain any active ingredients. It's used to compare against the real medicine to see its true effects.
Werde ich wissen, ob ich das echte Medikament oder das Placebo erhalte?
No, neither you nor the study team will know. This is called 'blinding' and helps ensure the study results are as fair and accurate as possible.
What does 'adverse events' mean?
Adverse events are any unwanted or unexpected medical problems that happen during a study. They are carefully monitored to understand the safety of the medicine.
Wie Sie mehr erfahren können
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Interessiert daran, teilzunehmen?
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.